Illumina(ILMN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ILMN Illumina

盘前交易 06-12 04:30:06 EDT

166.21

+3.74

+2.30%

盘前168.02

+1.81+1.09%

04:14 EDT

最高166.21	最低160.65	成交量148.70万
今开162.47	昨收162.47	日振幅3.42%
总市值252.48亿	流通市值248.23亿	总股本1.52亿
成交额2.44亿	换手率1.00%	流通股本1.49亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ILMN","market":"US","secType":"STK","nameCN":"Illumina","latestPrice":166.21,"timestamp":1781208000000,"preClose":162.47,"halted":0,"volume":1487031,"hourTrading":{"tag":"盘前","latestPrice":168.02,"preClose":166.21,"latestTime":"04:14 EDT","volume":20,"amount":3353.2,"timestamp":1781252053889,"change":1.81,"changeRate":0.01089,"amplitude":0.002407},"delay":0,"changeRate":0.023019634394042032,"floatShares":149346508,"shares":151906915,"eps":5.517285,"marketStatus":"盘前交易","change":3.74,"latestTime":"06-12 04:30:06 EDT","open":162.47,"high":166.21,"low":160.65,"amount":244198624.82652,"amplitude":0.034222,"askPrice":173.48,"askSize":27,"bidPrice":166.25,"bidSize":12,"shortable":3,"etf":0,"ttmEps":5.517285,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781271000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":964756800000,"exchange":"NASDAQ","adjPreClose":166.21,"preHourTrading":{"tag":"盘前","latestPrice":168.02,"preClose":166.21,"latestTime":"04:14 EDT","volume":20,"amount":3353.2,"timestamp":1781252053889,"change":1.81,"changeRate":0.01089,"amplitude":0.002407},"postHourTrading":{"tag":"盘后","latestPrice":166.3,"preClose":166.21,"latestTime":"19:49 EDT","volume":20313,"amount":3376222.1127,"timestamp":1781221751939,"change":0.09,"changeRate":0.000541,"amplitude":0.000541},"volumeRatio":0.732949,"impliedVol":0.4443,"impliedVolPercentile":0.456},"requestUrl":"/m/hq/s/ILMN","defaultTab":"news","newsList":[{"id":"2642143962","title":"Illumina推出StrataMap，一张芯片即可绘制组织内基因表达的“三维地图”","url":"https://stock-news.laohu8.com/highlight/detail?id=2642143962","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642143962?lang=zh_cn&edition=full","pubTime":"2026-06-09 03:26","pubTimestamp":1780946760,"startTime":"0","endTime":"0","summary":"基因测序服务提供商Illumina， Inc．今日正式宣布推出StrataMap空间解决方案。StrataMap每年可处理超过2000个样本，测序最短仅需22小时，从样本到数据洞察的全过程可在五天内完成。　　StrataMap空间解决方案于本月起正式开放订购，主要面向发育生物学、神经科学及肿瘤学等研究领域。此外，Illumina正在积极开发适用于福尔马林固定石蜡包埋组织的特异性解决方案，预计将于2027年向初始客户开放使用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-09/doc-iniattre6786480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4534","BK4588","ILMN","BK4585","LU0029874061.USD","BK4121","LU0128526141.USD","BK4535","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104054709","title":"Illumina推出Stratamap空间解决方案，打造强大端到端空间全转录组研究工具","url":"https://stock-news.laohu8.com/highlight/detail?id=1104054709","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104054709?lang=zh_cn&edition=full","pubTime":"2026-06-08 21:16","pubTimestamp":1780924583,"startTime":"0","endTime":"0","summary":"Illumina正式发布了其Stratamap空间解决方案，这是一款功能强大的端到端空间全转录组研究工具。该解决方案旨在为研究人员提供全面的技术平台，以深入探索组织样本中的基因表达空间信息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","LU0029874061.USD","BK4535","LU0128526141.USD","BK4585","BK4588","ILMN","BK4534","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639562759","title":"因美纳与SPT Labtech推出fireflyGO，助力更快速、更简便的肿瘤靶向研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2639562759","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639562759?lang=zh_cn&edition=full","pubTime":"2026-05-29 19:02","pubTimestamp":1780052520,"startTime":"0","endTime":"0","summary":"因美纳与SPT Labtech推出fireflyGO  \"因美纳致力于提供端到端的工作流程解决方案，帮助医疗健康与科研生态系统中的客户提升基因组检测的效率和可及性，\"因美纳全球临床解决方案部门副总裁兼总经理Sandy Ottensmann表示，\"fireflyGO平台结合因美纳MiSeq i100测序仪及Pillar Biosciences靶向panel检测，将进一步推动相关研究进展，促进癌症基因组检测的广泛应用，助力缩短周转时间从而更快获得检测结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4971148_ZH71148_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4535","BK4588","BK4585","ILMN","BK4023","BK4548","BK4534","SPT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117598904","title":"异动解读 | 因美纳推出高灵敏度MRD研究解决方案，股价盘中大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117598904","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117598904?lang=zh_cn&edition=full","pubTime":"2026-05-29 01:39","pubTimestamp":1779989974,"startTime":"0","endTime":"0","summary":"因美纳（Illumina，股票代码：ILMN）今日盘中股价大幅上涨5.14%，引起了市场的广泛关注。消息面上，因美纳公司宣布推出首个支持高灵敏度分子残留病灶研究的全基因组测序解决方案。该创新方案旨在为研究人员提供更强大的工具，以追踪和监测癌症治疗后体内可能残留的微量癌细胞，通过采用分布式方法提升测序的灵活性与可及性。这一新产品的发布，被视为公司在精准医疗和肿瘤学领域的重要进展，增强了市场对其技术领先地位和未来增长潜力的信心，从而推动了股价的上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ILMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120914551","title":"异动解读｜Illumina盘中上涨5.09%，推出全基因组癌症残留病灶检测工作流程","url":"https://stock-news.laohu8.com/highlight/detail?id=1120914551","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120914551?lang=zh_cn&edition=full","pubTime":"2026-05-29 01:39","pubTimestamp":1779989946,"startTime":"0","endTime":"0","summary":"5月28日，Illumina盘中上涨5.09%，报157.81美元/股，成交额1.41亿美元。消息面上，公司宣布推出首款用于高灵敏度微小残留病灶研究的分布式全基因组测序解决方案，并向部分临床研究合作伙伴开放早期使用权限。同行业中，安捷伦科技涨18.82%，ICON plc涨15.52%，Tempus AI涨8.43%，赛默飞世尔涨6.67%，丹纳赫涨4.01%，生命科学工具板块整体表现强势。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154498073","title":"Illumina推出首款用于高灵敏度微小残留病灶研究的分布式全基因组测序解决方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1154498073","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154498073?lang=zh_cn&edition=full","pubTime":"2026-05-28 21:16","pubTimestamp":1779974200,"startTime":"0","endTime":"0","summary":"Illumina推出了首款用于高灵敏度微小残留病灶（MRD）研究的分布式全基因组测序解决方案。这一创新方案旨在为研究人员提供更强大的工具，以追踪和监测癌症治疗后体内可能残留的微量癌细胞。通过采用分布式方法，该解决方案能够提升测序的灵活性与可及性，有望推动更精准的疾病监测与研究进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4121","BK4548","BK4585","BK4534","ILMN","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150708828","title":"Illumina发布2025年企业责任报告，拓展基因组学可及性并加速全球影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1150708828","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150708828?lang=zh_cn&edition=full","pubTime":"2026-05-20 04:31","pubTimestamp":1779222689,"startTime":"0","endTime":"0","summary":"Illumina发布了其2025年企业责任报告，重点阐述了公司在扩大基因组学技术的可及性以及加速其全球影响力方面所取得的进展。这份报告详细记录了公司如何通过创新与合作，致力于推动精准医疗的发展，并确保更多人群能够受益于先进的基因检测技术。此举旨在强化公司在可持续发展和社会责任领域的承诺，同时展示其在应对全球健康挑战方面的持续努力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4548","ILMN","BK4534","BK4121","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635709453","title":"股价3年翻4倍，市值超越龙头Illumina！这家“癌症早筛”公司被华尔街热捧","url":"https://stock-news.laohu8.com/highlight/detail?id=2635709453","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635709453?lang=zh_cn&edition=full","pubTime":"2026-05-15 15:39","pubTimestamp":1778830796,"startTime":"0","endTime":"0","summary":"癌症确诊后，肿瘤是否被彻底清除？这个价值200亿美元的问题，正让一家名不见经传的德州公司悄然超越基因测序巨头Illumina。Natera凭借近乎垄断的MRD检测技术，三年股价翻涨四倍，而当前仅6%的市场渗透率意味着，这场\"狙击癌症复发\"的生意才刚刚开始。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3772336","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4548","BK4534","BK4588","FAZ","ILMN","BK4535","BK4585"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1184338053","title":"异动解读 | Illumina盘中大涨6.01%，行业并购预期与专利诉讼双重提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1184338053","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184338053?lang=zh_cn&edition=full","pubTime":"2026-05-02 01:01","pubTimestamp":1777654889,"startTime":"0","endTime":"0","summary":"Illumina（ILMN）今日盘中大涨6.01%，引起了市场的广泛关注。消息面上，罗氏控股拟收购基因测序公司PacBio，行业整合预期升温，同时Illumina针对竞争对手Oxford Nanopore公司发起专利侵权诉讼，这些积极因素共同提振了市场情绪。此外，Illumina此前发布的第四季度财报表现稳健，收入达10.8亿美元，同比增长1.8%，每股收益1.25美元超分析师预期，基本面支撑也为股价上行提供了底气。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ILMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153221572","title":"财报前瞻｜Illumina本季度营收预计小幅增长，观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1153221572","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153221572?lang=zh_cn&edition=full","pubTime":"2026-04-23 10:53","pubTimestamp":1776912798,"startTime":"0","endTime":"0","summary":"Illumina将于2026年04月30日披露最新季度业绩，市场关注盈利修复与费用管控的进展。市场一致预期本季度Illumina营收约为10.73亿美元，同比增长4.12%；EBIT约为2.12亿美元，同比增长5.12%；调整后每股收益约为1.05美元，同比增长12.34%；若公司给出毛利率与净利率指引，当前预期并未明确披露。上一季度Illumina实现营收11.59亿美元，同比增长4.98%；毛利率为67.04%；归属于母公司的净利润为3.34亿美元，净利率为28.82%；调整后每股收益1.35美元，同比增长56.98%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜Illumina本季度营收预计小幅增长，观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135971339","title":"Dragen V4.5支持Illumina全新Trupath Genome及5-Base检测方案，赋能生殖系、肿瘤学与多组学工作流","url":"https://stock-news.laohu8.com/highlight/detail?id=1135971339","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135971339?lang=zh_cn&edition=full","pubTime":"2026-04-16 21:15","pubTimestamp":1776345331,"startTime":"0","endTime":"0","summary":"Dragen V4.5现已实现对Illumina公司最新推出的Trupath Genome和5-Base检测方案的全面兼容。这一重要升级显著增强了数据分析能力，为科研人员提供了更强大的工具，以深入探索生殖系遗传学、肿瘤学以及复杂的多组学工作流程。该平台通过优化算法和提升处理效率，旨在加速基因组学研究的进程，推动精准医疗领域的创新突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4588","ILMN","BK4121","BK4535","BK4585","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112357108","title":"Illumina与生物医学数据驱动发现中心携手推进基因组数据与可扩展软件在抗击儿童癌症及罕见病领域的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=1112357108","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112357108?lang=zh_cn&edition=full","pubTime":"2026-04-14 21:15","pubTimestamp":1776172522,"startTime":"0","endTime":"0","summary":"Illumina公司与生物医学数据驱动发现中心宣布达成合作，将整合基因组数据资源与可扩展的软件工具，共同致力于应对儿童癌症及罕见疾病的挑战。此次合作旨在通过先进的数据分析技术加速疾病机制研究，为精准医疗方案开发提供支持。双方将聚焦于构建高效的数据共享平台，推动儿科疾病诊疗领域的创新突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4535","ILMN","BK4588","BK4585","BK4121","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149678598","title":"Illumina推出伴行诊断开发服务 助力药企精准医疗布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1149678598","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149678598?lang=zh_cn&edition=full","pubTime":"2026-03-18 21:19","pubTimestamp":1773839987,"startTime":"0","endTime":"0","summary":"全球基因测序巨头Illumina宣布推出面向制药企业的伴行诊断开发服务。伴行诊断作为精准医疗的核心环节，能够通过检测特定生物标志物筛选适合药物治疗的患者群体。值得注意的是，Illumina此次服务的推出正值FDA加速推进个性化医疗审批的窗口期。分析师指出，这一战略举措将帮助Illumina进一步拓展其在医疗健康领域的业务边界。Illumina若能成功打造诊断开发服务平台，将有望在价值数千亿美元的精准医疗市场中占据更重要的位置。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4196","BK4548","BK4121","LU0742534661.SGD","LU0251142724.SGD","BK4534","LU0048573561.USD","ILMN","LU1059921491.USD","BK4535","LU2237438978.USD","LU0006061336.USD","BK4550","LU0251131958.USD","BK4588","LH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614053126","title":"因美纳推出TruPath Genome，树立基因组洞察新标准","url":"https://stock-news.laohu8.com/highlight/detail?id=2614053126","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614053126?lang=zh_cn&edition=full","pubTime":"2026-02-25 23:06","pubTimestamp":1772031960,"startTime":"0","endTime":"0","summary":"因美纳推出TruPath Genome，树立基因组洞察新标准  凭借极简工作流程，TruPath Genome免去了传统的文库制备环节。仅需约10分钟的手动操作时间，TruPath Genome即可实现每日产出16例全基因组数据，通量几乎是同类长读长方法的两倍，同时错误更少。TruPath Genome可对高达98%的基因实现完整定相。\"凭借TruPath Genome，我们正在突破基因组学的边界，并为遗传病与罕见病研究树立新的标准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4895607_ZH95607_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4534","BK4121","BK4585","BK4548","ILMN","BK4196","BK4588","BK4535","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179637480","title":"Illumina合作伙伴突破基因组边界，运用空间转录组学、表观基因组学与蛋白质组学推动癌症研究新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1179637480","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179637480?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:16","pubTimestamp":1772028976,"startTime":"0","endTime":"0","summary":"Illumina的合作伙伴正突破传统基因组学的局限，通过整合空间转录组学、表观基因组学及蛋白质组学三大前沿技术，在癌症研究领域取得重大进展。这些创新方法使科学家能够以更高分辨率解析肿瘤微环境，揭示癌细胞与免疫系统相互作用的动态过程，为开发精准抗癌疗法开辟新路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4548","BK4534","BK4588","ILMN","BK4535","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613716492","title":"因美纳发布NovaSeq X创新升级路线图：数据质量、读数产出、速度与灵活性全面提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2613716492","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613716492?lang=zh_cn&edition=full","pubTime":"2026-02-24 19:39","pubTimestamp":1771933140,"startTime":"0","endTime":"0","summary":"因美纳发布NovaSeq X创新升级路线图：数据质量、读数产出、速度与灵活性全面提升  这些升级将共同提升每日测序生产力，并扩大单台仪器可规模化运行的应用范围。\"NovaSeq X性能日益提升、更具成本效益、运行效率更快。\" 上述更新将陆续覆盖所有NovaSeq X测序仪，使现有用户与未来采用者均可受益。因美纳NovaSeq X测序仪在全球范围内服务于科研与临床实验室，助力推动科学进步并改善人类健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4894323_ZH94323_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4534","BK4585","BK4535","BK4548","BK4588","ILMN","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610638549","title":"小摩下调Illumina目标价至120美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610638549","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610638549?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:53","pubTimestamp":1770627227,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","BK4121","ILMN","BK4534","BK4585","BK4535","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608429823","title":"因美纳3.5亿美元收购SomaLogic拓展多组学能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2608429823","media":"DoNews","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608429823?lang=zh_cn&edition=full","pubTime":"2026-02-03 15:56","pubTimestamp":1770105363,"startTime":"0","endTime":"0","summary":"2026年1月30日，美国基因测序巨头因美纳（Illumina）宣布完成对蛋白质组学企业SomaLogic的收购。交易以3.5亿美元现金从Standard BioTools购得SomaLogic及相关资产，并附带最高7500万美元绩效里程碑款及后续业绩版税，资金源自公司自有现金。此次收购旨在整合基因组学与蛋白质组学技术，强化药物研发支持能力。因美纳计划于2月5日财报电话会议中披露交易财务影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203155818a47697ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203155818a47697ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4614","LU0719512351.SGD","AMDD","LU2054465674.USD","LU0823421416.USD","LU1951200564.SGD","BK4529","AMYY","BK4512","IE0004445239.USD","ILMN","LU1064131342.USD","BK4612","LU1880398554.USD","LU2264538146.SGD","LU0056508442.USD","LU1803068979.SGD","BK4554","LU1923623000.USD","LU2458330243.SGD","BK4588","LU1861559042.SGD","BK4532","AMDY","DAMD","LU0390134368.USD","LU0109392836.USD","BK4605","LU2458330169.SGD","AMDG","LU2355687059.USD","LU0082616367.USD","LU0889565833.HKD","LU1951198990.SGD","LU0274383776.USD","BK4534","LU0198837287.USD","LU0979878070.USD","AMDW","LU0642271901.SGD","BK4575","LU1988902786.USD","LU1861558580.USD","IE00BMPRXR70.SGD","LU2250418816.HKD","BK4543","BK4573","LU1303367103.USD","IE00BMPRXN33.USD","LU1989764664.SGD","LU1316542783.SGD","AMD","LU1242518857.USD","AMUU","LU2360106780.USD","BK4141","AMDL","BK4566","LU0127658192.USD","LU1880398471.USD","LU0081259029.USD","LU1242518931.SGD","LU2089985449.USD","LU0823434740.USD","LU1852331112.SGD","LU0823434583.USD","LU2098885051.SGD","IE0009356076.USD","LU2931357623.SGD","IE00B5949003.HKD","BK4585","AMDU","LU0823421333.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607040327","title":"因美纳完成对SomaLogic的收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2607040327","media":"美通社","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607040327?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:05","pubTimestamp":1769781900,"startTime":"0","endTime":"0","summary":"SomaLogic是数据驱动型蛋白质组学技术领域的领导者。因美纳完成对SomaLogic的收购  \"欢迎SomaLogic团队加入因美纳，这是我们落实2024年制定的多组学战略的重要里程碑。自2021年末以来，因美纳与SomaLogic已在蛋白质组学联合开发方面开展合作，并达成协议，将SomaScan蛋白质组学检测方案引入因美纳高通量NGS平台。因美纳以3.5亿美元从Standard BioTools收购SomaLogic及其他指定资产，交易金额根据惯例进行调整，现金款项在交易完成时支付，外加高达7,500万美元的近期绩效里程碑款项及业绩相关版税。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4875103_ZH75103_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["ILMN","BK4535","BK4585","BK4179","BK4121","NGS","BK4548","BK4534","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132715631","title":"财报前瞻｜Illumina本季度营收预计增1.80%，机构观点偏审慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1132715631","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132715631?lang=zh_cn&edition=full","pubTime":"2026-01-29 10:30","pubTimestamp":1769653842,"startTime":"0","endTime":"0","summary":"Illumina将于2026年02月05日发布最新季度财报，市场预期营收与利润将温和改善，关注耗材动能与利润率回升。市场一致预期本季度Illumina总收入为11.04亿美元，同比增长1.80%；调整后每股收益为1.23美元，同比增长34.06%；EBIT为2.51亿美元，同比增长14.58%，当前未有可核实的本季度毛利率与净利率预测口径，公司对本季度的毛利率与净利率预测未披露可用数据。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜Illumina本季度营收预计增1.80%，机构观点偏审慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILMN"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.illumina.com","stockEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":0.1408},{"period":"3month","weight":0.3974},{"period":"6month","weight":0.2324},{"period":"1year","weight":0.8987},{"period":"ytd","weight":0.2672}],"compareEarnings":[{"period":"1week","weight":-0.0255},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.114},{"period":"6month","weight":0.0821},{"period":"1year","weight":0.2268},{"period":"ytd","weight":0.0819}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Illumina, Inc.是一家生命科学用具以及用于分析基因变异和基因功能的整合系统的一流开发商、制造商和销售商。公司于1998年4月在加利福尼亚州组成，2000年7月在特拉华州完成重组。公司利用专利技术提供一系列的基因分析方案以及为高度相联的市场提供产品和服务，包括基因序列、基因类型、基因表达和分子诊断市场。该公司的客户包括领先的基因组研究中心、学术机构、政府管辖的实验室、临床研究组织以及制药公司、生物科技公司、农产品基因组鉴定研发公司和客户基因组鉴定公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.692308,"avgChangeRate":0.092312},{"month":2,"riseRate":0.346154,"avgChangeRate":-0.045009},{"month":3,"riseRate":0.538462,"avgChangeRate":-0.001071},{"month":4,"riseRate":0.615385,"avgChangeRate":0.017533},{"month":5,"riseRate":0.576923,"avgChangeRate":0.048376},{"month":6,"riseRate":0.730769,"avgChangeRate":0.036591},{"month":7,"riseRate":0.72,"avgChangeRate":0.021401},{"month":8,"riseRate":0.423077,"avgChangeRate":-0.005012},{"month":9,"riseRate":0.461538,"avgChangeRate":-0.001717},{"month":10,"riseRate":0.576923,"avgChangeRate":0.02947},{"month":11,"riseRate":0.576923,"avgChangeRate":0.011167},{"month":12,"riseRate":0.615385,"avgChangeRate":0.029102}],"exchange":"NASDAQ","name":"Illumina","nameEN":"Illumina"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Illumina(ILMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Illumina(ILMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Illumina,ILMN,Illumina股票,Illumina股票老虎,Illumina股票老虎国际,Illumina行情,Illumina股票行情,Illumina股价,Illumina股市,Illumina股票价格,Illumina股票交易,Illumina股票购买,Illumina股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Illumina(ILMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Illumina(ILMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}